A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults
David J Gattas, Dorrilyn Rajbhandari, Celia Bradford, Heidi Buhr, Serigne Lo, Rinaldo Bellomo
Critical Care Medicine | LIPPINCOTT WILLIAMS & WILKINS | Published : 2015
Supported, in part, by Intensive Care Foundation, Carlton, VIC, Australia, and Austin ICU Research Fund, Heidelberg, VIC, Australia. The study sponsors had no role or authority in the design, collection, management, analysis or interpretation of data, writing of the report, or decision to submit for publication.Dr. Gattas lectured for Baxter. His institution received grant support from the Intensive Care Foundation (AUD$55K competitive grant from charitable foundation; no industry funding). Ms. Rajbhandari's institution received grant support from Intensive Care Foundation. Dr. Bradford's institution received grant support from the Intensive Care Foundation Grant. Ms. Buhr received support for article research from the Intensive Care Foundation. Her institution received grant support from the Intensive Care Foundation. Dr. Bellomo consulted for Baxter and BBraun. Dr. Lo has disclosed that he does not have any potential conflicts of interest.